Suchergebnisse - "Maggiolo, Franco"

PubPharm (257)

1

Factors Associated with Low-Level Viremia in People Living with HIV in the Italian Antiviral Response Cohort Analysis Cohort : A Case-Control Study

enthalten in: AIDS research and human retroviruses | 2024

von Lombardi, F. | Bruzzesi, E. | Bouba, Y. | +13

2

Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy : 96-week pooled analysis

enthalten in: AIDS (London, England) | 2024

von Orkin, C. | Antinori, A. | Rockstroh, J. | +11

3

Cohort profile : PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors

enthalten in: BMJ open | 2024

von Clemente, T. | Galli, L. | Lolatto, R. | +17

4

Optimizing the antiretroviral treatment focusing on long-term effectiveness and a person-centered approach. Consensus Guidance Using a Delphi Process

enthalten in: The new microbiologica | 2024

von Maggiolo, F. | Lo Caputo, S. | Bonora, S. | +9

5

Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV

enthalten in: iScience | 2024

von Augello, M. | Bono, V. | Rovito, R. | +9

6

Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens : Data from the ICONA cohort

enthalten in: International journal of antimicrobial agents | 2024

von Gagliardini, R. | Tavelli, A. | Rusconi, S. | +14

7

Pillars of long-term antiretroviral therapy success

enthalten in: Pharmacological research | 2023

von Taramasso, L. | Andreoni, M. | Antinori, A. | +36

8

Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1 : five-year follow-up from two randomized trials

enthalten in: EClinicalMedicine | 2023

von Sax, P. | Arribas, J. | Orkin, C. | +13

9

Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry

enthalten in: International journal of antimicrobial agents | 2023

von Saladini, F. | Giammarino, F. | Maggiolo, F. | +12

10

Real world efficacy of dolutegravir plus lamivudine in people living with HIV with undetectable viral load after previous failures

enthalten in: Journal of global antimicrobial resistance | 2023

von Gagliardini, R. | Lorenzini, P. | Cozzi-Lepri, A. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]